Chemical modulation of Kv7 potassium channels
Open accessThe DOI matches its Crossref record; 386 of the 386 references it cites were found in a registry or an index.
Abstract
This review describes the synthetic and medicinal chemistry of small molecule modulators of the voltage-gated Kv7 (KCNQ) potassium channels and the available data of their biological and clinical properties.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Natural-product leads like echinocystic acid and endogenous modulators such as dehydroepiandrosterone sulfate (DHEAS) expand chemotype space and suggest allosteric stabilization strategies that preserve physiological gating [267,269].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [267]
In the citing paper
“Structure-guided chemistry and in silico design have produced Kv7.2/7.3-biased agonists with order-of-magnitude potency gains over retigabine, improved pharmacokinetics, and reduced liabilities linked to earlier chemotypes [265,266,267].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [267]
In the citing paper
“Brain-penetrant exemplars such as Lu AA41178 and SCR2682, pan-Kv7 (KCNQ2–5) potassium-channel activators, demonstrate broad antiexcitability efficacy without major off-target activity, while clinical candidates including azetukalner and BHV-7000, Kv7.2/7.3-selective channel activators, aim to retain efficacy while avoiding pigmentation and urinary liabilities associated with earlier chemotypes [”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [267]
Citations
Cites
Items 201–386 of 386
Sun, Z., THOMAS, G. P., & Antzelevitch, C. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.00472.x · Cited by 52
Wang, J., Wang, L., Zheng, J., Anderson, J. L., & Toews, M. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.4.687 · Cited by 52
A case report: retigabine induced oral mucosal dyspigmentation of the hard palate
Beacher, N. G., Brodie, M. J., & Goodall, C. (2015) · BMC Oral Health · doi:10.1186/s12903-015-0102-y · Cited by 51
Kovalchuk, M. O., Heuberger, J. A. A. C., Sleutjes, B. T. H. M., Ziagkos, D., van den Berg, L. H., Ferguson, T. A., Franssen, H., & Groeneveld, G. J. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1096 · Cited by 51
Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19857818 · Cited by 51
Brueggemann, L. I., Haick, J. M., Cribbs, L. L., & Byron, K. L. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093799 · Cited by 51
Alverez, C. N., Arkin, M. R., Bulfer, S. L., Colombo, R., Kovaliov, M., LaPorte, M. G., Lim, C., Liang, M., Moore, W. J., Neitz, R. J., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00364 · Cited by 51
Self-citationNeuronal potassium channel openers in the management of epilepsy: role and potential of retigabine
Taglialatela, M., Barrese, Miceli, Soldovieri, Ambrosino, Iannotti, & Cilio (2010) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s15369 · Cited by 50
M‐type channels selectively control bursting in rat dopaminergic neurons
Drion, G., Bonjean, M., Waroux, O., Scuvée‐Moreau, J., Liégeois, J., Sejnowski, T. J., Sepulchre, R., & Seutin, V. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07107.x · Cited by 50
Qi, J., Zhang, F., Mi, Y. M., Fu, Y., Xu, W., Zhang, D.-Q., Wu, Y., Du, X., Jia, Q., Wang, K., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.010 · Cited by 50
Management of Multiple Sclerosis Relapses
Repovic, P. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000739 · Cited by 49
Bett, G. C. L., Morales, M. J., Beahm, D. L., Duffey, M. E., & Rasmusson, R. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.116012 · Cited by 48
Xu, X., Salata, J. J., Wang, J., Wu, Y., Yan, G., Liu, T., Marinchak, R. A., & Kowey, P. R. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00076.2002 · Cited by 48
Amato, G., Roeloffs, R., Rigdon, G. C., Antonio, B., Mersch, T., McNaughton-Smith, G., Wickenden, A. D., Fritch, P., & Suto, M. J. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200053x · Cited by 48
The anticonvulsant retigabine is a subtype selective modulator of GABAAreceptors
Treven, M., Koenig, X., Assadpour, E., Gantumur, E., Meyer, C., Hilber, K., Boehm, S., & Kubista, H. (2015) · Epilepsia · doi:10.1111/epi.12950 · Cited by 48
Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites
Miceli, F., Soldovieri, M. V., Ambrosino, P., Manocchio, L., Mosca, I., & Taglialatela, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666171012122852 · Cited by 48
Soh, H., & Tzingounis, A. V. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066100 · Cited by 48
Yang, I. C.-H., Scherz, M. W., Bahinski, A., Bennett, P. B., & Murray, K. T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39158-x · Cited by 48
Peng, H., Bian, X.-L., Ma, F.-C., & Wang, K.-W. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.72 · Cited by 48
Expression and function of Kv7 channels in murine myometrium throughout oestrous cycle
McCallum, L. A., Greenwood, I. A., & Tribe, R. M. (2008) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-008-0567-5 · Cited by 47
Tiwari, M. N., Mohan, S., Biala, Y., & Yaari, Y. (2018) · Hippocampus · doi:10.1002/hipo.22836 · Cited by 47
Seizures and the Role of Anticonvulsants After Traumatic Brain Injury
Zimmermann, L. L., Diaz-Arrastia, R. R., & Vespa, P. M. (2016) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2016.06.001 · Cited by 46
Brickel, N., Hewett, K., Rayner, K., McDonald, S., De'Ath, J., Daniluk, J., Joshi, K., Boll, M. C., Tiamkao, S., Vorobyeva, O., et al. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106580 · Cited by 46
Investigation of the in Vitro Metabolism of the Analgesic Flupirtine
Methling, K., Reszka, P., Lalk, M., Vrána, O., Scheuch, E., Siegmund, W., Terhaag, B., & Bednarski, P. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024364 · Cited by 46
Zhang, F., Mi, Y., Qi, J., Li, J., Si, M., Guan, B., Du, X., An, H., & Zhang, H. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02232.x · Cited by 44
Discovery of a Novel Activator of KCNQ1-KCNE1 K+ Channel Complexes
Mruk, K., & Kobertz, W. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004236 · Cited by 44
Aiken, S. P., Zaczek, R. C., & Brown, B. S. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60281-1 · Cited by 43
Restoration of ion channel function in deafness‐causing KCNQ4 mutants by synthetic channel openers
Leitner, M. G., Feuer, A., Ebers, O., Schreiber, D. N., Halaszovich, C. R., & Oliver, D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01697.x · Cited by 43
Probing Binding Sites and Mechanisms of Action of an I Ks Activator by Computations and Experiments
Xu, Y., Wang, Y., Zhang, M., Jiang, M., Rosenhouse‐Dantsker, A., Wassenaar, T. A., & Tseng, G. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.10.059 · Cited by 43
Bierbower, S. M., Choveau, F. S., Lechleiter, J. D., & Shapiro, M. S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-14.2015 · Cited by 43
Kinarivala, N., Patel, R., Boustany, R., Al-Ahmad, A. J., & Trippier, P. C. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01199 · Cited by 43
Vasorelaxant effects of novel Kv 7.4 channel enhancers ML 213 and NS 15370
Jepps, T. A., Bentzen, B. H., Stott, J. B., Povstyan, O. V., Sivaloganathan, K., Dalby‐Brown, W., & Greenwood, I. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12805 · Cited by 42
Mani, B. K., O’Dowd, J., Kumar, L., Brueggemann, L. I., Ross, M., & Byron, K. L. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182771708 · Cited by 42
Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels
Du, X., Zhang, X., Qi, J., An, H., Li, J., Wan, Y., Fu, Y., Gao, H., Gao, Z., Zhan, Y., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01483.x · Cited by 41
Kalgutkar, A. S. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141112122118 · Cited by 41
Desensitization of Chemical Activation by Auxiliary Subunits
Gao, Z., Xiong, Q., Sun, H., & Li, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802426200 · Cited by 41
Synthesis and Structure−Activity Relationship of Acrylamides as KCNQ2 Potassium Channel Openers
Wu, Y., He, H. Q., Sun, L., L’Heureux, A., Chen, J., Dextraze, P., John E. Starrett, Boissard, C. G., Gribkoff, V. K., Natale, J. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0305826 · Cited by 40
Medial septal dysfunction by Aβ-induced KCNQ channel-block in glutamatergic neurons
Leão, R. N., Colom, L. V., Borgius, L., Kiehn, O., & Fisahn, A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.07.013 · Cited by 39
Ostacolo, C., Miceli, F., Di Sarno, V., Nappi, P., Iraci, N., Soldovieri, M. V., Ciaglia, T., Ambrosino, P., Vestuto, V., Lauritano, A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00796 · Cited by 39
ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling
Hou, P., Shi, J., White, K. M., Gao, Y., & Cui, J. (2019) · eLife · doi:10.7554/elife.48576 · Cited by 39
Peretz, A., Degani-Katzav, N., Talmon, M., Danieli, E., Gopin, A., Malka, E., Nachman, R., Raz, A., Shabat, D., & Attali, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001332 · Cited by 38
Gao, H., Boillat, A., Huang, D., Liang, C., Peers, C., & Gamper, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620598114 · Cited by 38
Gratzke, C., Christ, G. J., Stief, C. G., Andersson, K., & Hedlund, P. (2009) · European Urology · doi:10.1016/j.eururo.2008.12.024 · Cited by 38
Wrobel, E., Rothenberg, I., Krisp, C., Hundt, F., Fraenzel, B., Eckey, K., Linders, J. T. M., Gallacher, D. J., Towart, R., Pott, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12795 · Cited by 38
Yu, T., Li, L., Liu, H., Li, H., Liu, Z., & Li, Z. (2018) · Molecular Pain · doi:10.1177/1744806918793229 · Cited by 38
Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?
Lawson, K. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1437 · Cited by 37
Boger, D. L., & Zarrinmayeh, H. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00291a059 · Cited by 37
Pharmacological Manipulation of Kv7 Channels as a New Therapeutic Tool for Multiple Brain Disorders
Vigil, F. A., Carver, C. M., & Shapiro, M. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00688 · Cited by 36
Sheppard, A., Chen, G., & Salvi, R. (2015) · Hearing Research · doi:10.1016/j.heares.2015.04.007 · Cited by 36
Lobariñas, E., Dalby‐Brown, W., Stolzberg, D. J., Mirza, N. R., Allman, B. L., & Salvi, R. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.05.022 · Cited by 36
Miceli, F., Cilio, M. R., Taglialatela, M., & Bezanilla, F. (2009) · Channels · doi:10.4161/chan.3.4.9477 · Cited by 36
Ipavec, V., Martire, M., Barrese, V., Taglialatela, M., & Currò, D. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.06.016 · Cited by 36
Teng, B.-C., Song, Y., Zhang, F., Ma, T.-Y., Qi, J.-L., Zhang, H.-L., Li, G., & Wang, K. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.33 · Cited by 36
Authier, S., Pugsley, M. K., Koerner, J. E., Fermini, B., Redfern, W. S., Valentin, J., Vargas, H. M., Leishman, D. J., Correll, K. G., & Curtis, M. J. (2017) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2017.02.021 · Cited by 36
Promising Targets for the Treatment of Neurodegenerative Diseases
Budd Haeberlein, S., & Harris, T. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.195 · Cited by 35
The anticonvulsant retigabine suppresses neuronal KV2-mediated currents
Stas, J. I., Bocksteins, E., Jensen, C. S., Schmitt, N., & Snyders, D. J. (2016) · Scientific Reports · doi:10.1038/srep35080 · Cited by 35
Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania
Redrobe, J. P., & Nielsen, A. N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.027 · Cited by 34
Wang, K., McIlvain, B., Tseng, E., Kowal, D. M., Jow, F., Shen, R., Zhang, H., Shan, Q. J., He, L., Chen, D. A., et al. (2004) · Assay and Drug Development Technologies · doi:10.1089/adt.2004.2.525 · Cited by 34
Afeli, S. A. Y., Malysz, J., & Petkov, G. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075875 · Cited by 33
Luykx, J. J., Boks, M. P., Terwindt, A. P. R., Bakker, S. C., Kahn, R. S., & Ophoff, R. A. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.008 · Cited by 33
Metabolic evidence of corticolimbic dysregulation in bipolar mania
Brooks, J. O., Hoblyn, J. C., & Ketter, T. A. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.08.006 · Cited by 33
Inactivation as a New Regulatory Mechanism for Neuronal Kv7 Channels
Jensen, H. S., Grunnet, M., & Olesen, S. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.101287 · Cited by 33
Ling, J. J., Erol, F., Viatchenko‐Karpinski, V., Kanda, H., & Gu, J. G. (2017) · Molecular Pain · doi:10.1177/1744806917724715 · Cited by 33
Liu, L., Wang, F., Lu, H., Ren, X., & Zou, J. (2014) · Islets · doi:10.4161/19382014.2014.962386 · Cited by 32
Howells, J., Matamala, J. M., Park, S. B., Garg, N., Vucic, S., Bostock, H., Burke, D. J., & Kiernan, M. C. (2018) · The Journal of Physiology · doi:10.1113/jp276624 · Cited by 32
Carrillo‐Reid, L., Day, M., Xie, Z., Melendez-Zaidi, A. E., Kondapalli, J., Plotkin, J. L., Wokosin, D. L., Chen, Y., Kress, G. J., Kaplitt, M. G., et al. (2019) · eLife · doi:10.7554/elife.40818 · Cited by 32
Li, L., Li, J., Zuo, Y., Dang, D., Frost, J. A., & Yang, Q. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.11.001 · Cited by 31
Cheung, Y., Yu, H., Xu, K., Zou, B., Wu, M., McManus, O. B., Li, M., Lindsley, C. W., & Hopkins, C. R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300700v · Cited by 31
Jepps, T. A., Olesen, S., Greenwood, I. A., & Dalsgaard, T. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13444 · Cited by 31
KCNQ/M-channels regulate mouse vagal bronchopulmonary C-fiber excitability and cough sensitivity
Sun, H., Lin, A., Ru, F., Patil, M. J., Meeker, S., Lee, L., & Undem, B. J. (2019) · JCI Insight · doi:10.1172/jci.insight.124467 · Cited by 31
Earl, R. A., Zaczek, R. C., Teleha, C. A., Fisher, B. N., Maciag, C. M., Marynowski, M. E., Logue, A. R., Tam, S. W., Tinker, W. J., Huang, S. M., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9803424 · Cited by 31
Klinger, F., Bajrić, M., Salzer, I., Dorostkar, M. M., Khan, D., Pollak, D. D., Kubista, H., Boehm, S., & Koenig, X. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13262 · Cited by 30
Liu, H., Jia, L., Chen, X., Shi, L., & Xie, J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.11.011 · Cited by 30
Wang, L., Qiao, G.-H., Hu, H., Gao, Z., & Nan, F. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00315 · Cited by 30
Tiwari, M. N., Mohan, S., Biala, Y., & Yaari, Y. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1603-19.2019 · Cited by 30
Herrmann, W. M., Kern, U., & Aigner, M. (1987) · PubMed · Cited by 29
Differential Effects of ICA-27243 on Cloned KV7 Channels
Blom, S. M., Schmitt, N., & Jensen, H. S. (2010) · Pharmacology · doi:10.1159/000317525 · Cited by 29
Bladder contractility is modulated by Kv7 channels in pig detrusor
Svalø, J., Bille, M., Theepakaran, N. P., Sheykhzade, M., Nordling, J., & Bouchelouche, P. N. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.005 · Cited by 29
Sander, S. E., Lemm, C., Lange, N., Hamann, M., & Richter, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.10.016 · Cited by 29
Alberdi, A., Gomis‐Pérez, C., Bernardo‐Seisdedos, G., Alaimo, A., Malo, C., Aldaregia, J., Lopez-Robles, C., Areso, P., Butz, E. S., Wahl‐Schott, C., et al. (2015) · Journal of Cell Science · doi:10.1242/jcs.176420 · Cited by 29
Treatment of myotonia congenita with retigabine in mice
Dupont, C., Denman, K., Hawash, A. A., Voss, A. A., & Rich, M. M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.02.002 · Cited by 29
Activation of peripheral KCNQ channels relieves gout pain
Zheng, Y., Xu, H., Zhan, L., Zhou, X., Chen, X., & Gao, Z. (2015) · Pain · doi:10.1097/j.pain.0000000000000122 · Cited by 28
Durán-González, J., Michi, E. D., Elorza, B., Perez-Cordova, M. G., Otalora, L. F. P., Touhami, A., Paulson, P. E., Perry, G. L., Murray, I. V. J., & Colom, L. V. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.02.005 · Cited by 28
Ryanodine receptors as leak channels.
Guerrero-Hernández, A., Ávila, G., & Rueda, A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.016 · Cited by 28
Blom, S. M., Schmitt, N., & Jensen, H. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008251 · Cited by 28
Wu, Y., Boissard, C. G., Chen, J., Fitzpatrick, W., Gao, Q., Gribkoff, V. K., Harden, D., He, H., Knox, R. J., Natale, J. T., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.01.069 · Cited by 28
Flupirtine and retigabine as templates for ligand-based drug design of K V 7.2/3 activators
Surur, A. S., Bock, C., Beirow, K., Wurm, K. W., Schulig, L., Kindermann, M. K., Siegmund, W., Bednarski, P. J., & Link, A. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob00511k · Cited by 28
Douša, M., Srbek, J., Rádl, S., Černý, J., Klecán, O., Havlı́ček, J., Tkadlecová, M., Pekárek, T., Gibala, P., & Nováková, L. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.01.042 · Cited by 27
Electrical Resonance in the θ Frequency Range in Olfactory Amygdala Neurons
Vera, J. R., Pezzoli, M., Pereira, U., Bacigalupo, J., & Sanhueza, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085826 · Cited by 27
Sulfide Analogues of Flupirtine and Retigabine with Nanomolar KV7.2/KV7.3 Channel Opening Activity
Bock, C., Surur, A. S., Beirow, K., Kindermann, M. K., Schulig, L., Bodtke, A., Bednarski, P. J., & Link, A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900112 · Cited by 27
M-Current Expands the Range of Gamma Frequency Inputs to Which a Neuronal Target Entrains
Zhou, Y., Vo, T., Rotstein, H. G., McCarthy, M. M., & Kopell, N. (2018) · The Journal of Mathematical Neuroscience · doi:10.1186/s13408-018-0068-6 · Cited by 27
Pieniaszek, H. J., Fiske, W. D., Saxton, T. D., Kim, Y. S., Garner, D. M., Xilinas, M., & Martz, R. C. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04741.x · Cited by 26
Characterization of a novel high-potency positive modulator of Kv7 channels
Dalby‐Brown, W., Jessen, C., Hougaard, C. Ø., Jensen, M. L., Jacobsen, T. A., Nielsen, K. S., Erichsen, H. K., Grunnet, M., Ahring, P. K., Christophersen, P., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.039 · Cited by 26
Hexachlorophene Is a Potent KCNQ1/KCNE1 Potassium Channel Activator Which Rescues LQTs Mutants
Zheng, Y., Zhu, X., Zhou, P., Lan, X., Xu, H., Li, M., & Gao, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051820 · Cited by 26
Seydel, J. K., Schaper, K. ‐., Coats, E. A., Cordes, H. P., Emig, P., Engel, J., Kutscher, B., & Polymeropoulos, E. E. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00045a005 · Cited by 26
Functional effects of KCNQ K+ channels in airway smooth muscle
Evseev, A. I., Semenov, I., Archer, C. R., Medina, J., Dube, P. H., Shapiro, M. S., & Brenner, R. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00277 · Cited by 26
Seefeld, M. A., Lin, H., Holenz, J., Downie, D., Donovan, B., Fu, T., Pasikanti, K., Zhen, W., Cato, M., Chaudhary, K. W., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.036 · Cited by 26
Jung, J., Choi, H. B., Koh, Y. I., Rim, J. H., Choi, H. J., Kim, S. H., Lee, J., An, J., Kim, A., Lee, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34876-9 · Cited by 26
Svalø, J., Sheykhzade, M., Nordling, J., Matras, C., & Bouchelouche, P. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117350 · Cited by 25
Wu, S., Yang, W.-H., Yeh, C.-C., & Huang, H.-C. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0805-7 · Cited by 25
Cao, Y., Bartolomé‐Martín, D., Rotem, N., Rozas, C., Dellal, S. S., Chacón, M. A., Kadriu, B., Gulinello, M. E., Khodakhah, K., & Faber, D. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405748112 · Cited by 25
Bachmann, A., Quast, U., & Ruß, U. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100410 · Cited by 25
Role of High‐Throughput Electrophysiology in Drug Discovery
Liu, C., Li, T., & Chen, J. (2019) · Current Protocols in Pharmacology · doi:10.1002/cpph.69 · Cited by 25
Extracellular Potassium Inhibits Kv7.1 Potassium Channels by Stabilizing an Inactivated State
Larsen, A. P., Steffensen, A. B., Grunnet, M., & Olesen, S. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.06.034 · Cited by 24
Kv7 (KCNQ) potassium channels that are mutated in human diseases
Brown, D. A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.153007 · Cited by 24
Discovery of a novel Kv7 channel opener as a treatment for epilepsy
Davoren, J. E., Claffey, M. M., Snow, S. L., Reese, M. R., Arora, G., Butler, C. R., Boscoe, B. P., Chenard, L. K., DeNinno, S. L., Drozda, S. E., et al. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.074 · Cited by 24
Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety
Reffelmann, T., & Kloner, R. A. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.3.531 · Cited by 24
How to Replace the Lost keys? Strategies Toward Safer K V 7 Channel Openers
Bock, C., & Link, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0350 · Cited by 24
Boehlen, A., Schwake, M., Dost, R., Kunert, A., Fidzinski, P., Heinemann, U., & Gebhardt, C. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12065 · Cited by 23
A Large Scale Preparation of the Cognitive Enhancer Linopirdine
Bryant, W. M., Huhn, G. F., Jensen, J. H., Pierce, M. E., & Stammbach, C. (1993) · Synthetic Communications · doi:10.1080/00397919308011258 · Cited by 23
Fujisawa, S., Ono, K., & Iijima, T. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703126 · Cited by 23
S1 Constrains S4 in the Voltage Sensor Domain of Kv7.1 K+ Channels
Haitin, Y., Yisharel, I., Malka, E., Shamgar, L., Schöttelndreier, H., Peretz, A. S., Paas, Y., & Attali, B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001935 · Cited by 23
Magyar, J., Horváth, B., Bányász, T., Szentandrássy, N., Birinyi, P., Varró, A., Szakonyi, Z., Fülöp, F., & Nánási, P. P. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0047-4 · Cited by 23
Syeda, R., Santos, J. S., & Montal, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683185 · Cited by 23
Ge, L., & Liu, X. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.140 · Cited by 23
Provence, A., Angoli, D., & Petkov, G. V. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.243162 · Cited by 23
Action potential shortening rescues atrial calcium alternans
Kanaporis, G., Kalik, Z. M., & Blatter, L. A. (2018) · The Journal of Physiology · doi:10.1113/jp277188 · Cited by 23
Fibromyalgia Symptoms Relieved by Flupirtine: An Open-Label Case Series
Stoll, A. L. (2000) · Psychosomatics · doi:10.1176/appi.psy.41.4.371 · Cited by 22
Xia, X., Zhang, Q., Jia, Y., Shu, Y., Yang, J., Yang, H., & Yan, Z. (2020) · Hearing Research · doi:10.1016/j.heares.2020.107884 · Cited by 22
Kristensen, L. V., Sandager‐Nielsen, K., & Hansen, H. H. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07704.x · Cited by 21
Neurophysiological assessment of craniofacial pain
Galeotti, F., Truini, A., & Cruccu, G. (2006) · The Journal of Headache and Pain · doi:10.1007/s10194-006-0287-1 · Cited by 21
Molecular Mechanisms and Structural Basis of Retigabine Analogues in Regulating KCNQ2 Channel
Shi, S., Li, J., Sun, F., Chen, Y., Pang, C., Geng, Y.-Z., Qi, J., Guo, S., Wang, X., Zhang, H., et al. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00113-6 · Cited by 21
Pharmacologic Therapy for Erectile Dysfunction and its Interaction With the Cardiovascular System
Ioakeimidis, N., & Kostis, J. B. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413504034 · Cited by 21
Activation of KV7 channels stimulates vasodilatation of human placental chorionic plate arteries
Mills, T. A., Greenwood, S. L., Devlin, G., Shweikh, Y., Robinson, M., Cowley, E. J., Hayward, C. E., Cottrell, E. C., Tropea, T., Brereton, M. F., et al. (2015) · Placenta · doi:10.1016/j.placenta.2015.03.007 · Cited by 20
Feng, M., Crowley, N. A., Patel, A., Guo, Y., Bugni, S. E., & Luscher, B. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.03.003 · Cited by 20
Lesions of the lateral habenula improve working memory performance in hemiparkinsonian rats
Du, C., Liu, J., Guo, Y., Zhang, L., & Zhang, Q. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.10.027 · Cited by 20
Kreir, M., Bondt, A. D., den Wyngaert, I. V., Teuns, G., Lu, H. R., & Gallacher, D. J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172474 · Cited by 20
Wu, Y., Sun, L., He, H., Chen, J., Starrett, J. E., Dextraze, P., Daris, J., Boissard, C. G., Pieschl, R. L., Gribkoff, V. K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.035 · Cited by 19
Liu, R., Tzounopoulos, T., & Wipf, P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00097 · Cited by 19
Self-citationGrupe, M., Bentzen, B. H., Benned-Jensen, T., Nielsen, V., Frederiksen, K., Jensen, H. S., Jacobsen, A.-M., Skibsbye, L., Sams, A. G., Grunnet, M., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173440 · Cited by 19
Lemmerhirt, C. J., Rombach, M., Bodtke, A., Bednarski, P. J., & Link, A. (2014) · ChemMedChem · doi:10.1002/cmdc.201402442 · Cited by 19
Provence, A., Malysz, J., & Petkov, G. V. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225268 · Cited by 19
Shin, D. H., Jung, J., Koh, Y. I., Rim, J. H., Lee, J. S., Choi, H. J., Joo, S. Y., Yu, S., Cha, D. H., Lee, S. Y., et al. (2018) · Human Mutation · doi:10.1002/humu.23698 · Cited by 19
Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain
Zhang, F., Liu, S., Jin, L., Tang, L., Zhao, X., Yang, T., Wang, Y., Huo, B., Liu, R., & Li, H. (2020) · Pharmacology · doi:10.1159/000505934 · Cited by 19
Self-citationZhou, P., Zhang, Y., Xu, H., Chen, F., Chen, X., Li, X., Pi, X., Wang, L., Zhan, L., Nan, F., et al. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095190 · Cited by 18
Discovery of a retigabine derivative that inhibits KCNQ2 potassium channels
Hu, H.-N., Zhou, P., Chen, F., Li, M., Nan, F.-J., & Gao, Z.-B. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.79 · Cited by 18
Su, T.-R., Zei, W.-S., Su, C., Hsiao, G., & Lin, M.-J. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/803082 · Cited by 18
Huntington’s disease: Managing neuropsychiatric symptoms in Huntington’s disease
Loi, S. M., Walterfang, M., Velakoulis, D., & Looi, J. C. (2018) · Australasian Psychiatry · doi:10.1177/1039856218766120 · Cited by 18
Yue, J., Qiao, G.-H., Liu, N., Nan, F., & Gao, Z. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.142 · Cited by 17
Du, X. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00007-5 · Cited by 16
Nonsensing residues in S3–S4 linker’s C terminus affect the voltage sensor set point in K+ channels
Carvalho-de-Souza, J. L., & Bezanilla, F. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201711882 · Cited by 16
Surur, A. S., Beirow, K., Bock, C., Schulig, L., Kindermann, M. K., Bodtke, A., Siegmund, W., Bednarski, P. J., & Link, A. (2019) · ChemistryOpen · doi:10.1002/open.201800244 · Cited by 16
Promiscuous gating modifiers target the voltage sensor of K v 7.2, TRPV1, and H v 1 cation channels
Kornilov, P., Peretz, A. S., Lee, Y., Son, K., Lee, J. H., Refaeli, B., Roz, N., Rehavi, M., Choi, S., & Attali, B. (2014) · The FASEB Journal · doi:10.1096/fj.14-250647 · Cited by 15
Yang, S., Lu, D., & Ouyang, P. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.05.019 · Cited by 15
Hsu, H., Lo, Y., & Wu, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041441 · Cited by 15
Bauer, A., Koch, M., Kraft, P., Becker, R., Kelemen, K., Voss, F., Senges, J. C., Gerlach, U. V., Katus, H. A., & Schoels, W. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0522-y · Cited by 14
Chen, J.-G., Chen, J.-G., Markovitz, D. A., Yang, A. Y., Rabel, S. R., Pang, J., Dolinsky, O., Wu, L., & Alasandro, M. S. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102039 · Cited by 14
The Human Ether-A-Go-Go–Related Gene Activator NS1643 Enhances Epilepsy-Associated KCNQ Channels
Li, P., Chen, X., Zhang, Q., Zheng, Y., Jiang, H., Yang, H., & Gao, Z. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217703 · Cited by 14
Zhang, X., Jakubowski, M., Buettner, C., Kainz, V., Gold, M. S., & Burstein, R. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.02.029 · Cited by 14
Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators
Osuma, A. T., Xu, X., Wang, Z., Camp, J. A. V., & Freiberg, G. M. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.08.007 · Cited by 14
Blom, S. M., Rottländer, M., Kehler, J., Bundgaard, C., Schmitt, N., & Jensen, H. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100209 · Cited by 13
Zaczek, R. C., Tinker, W. J., & Tam, S. W. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90684-d · Cited by 13
Atrial Fibrillation Through the Years: Contemporary Evaluation and Management
Chinitz, J. S., Vaishnava, P., Narayan, R. L., & Fuster, V. (2013) · Circulation · doi:10.1161/circulationaha.112.120758 · Cited by 13
Bian, G., Liu, J., Guo, Y., Yang, Y., Li, L., Qiao, H., Li, W., Xu, T., & Zhang, Q. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108012 · Cited by 13
Wu, Y., Conway, C. M., Sun, L., Machet, F., Chen, J., Chen, P., He, H., Bourin, C., Calandra, V., Polino, J. L., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.092 · Cited by 12
Bauer, A., Becker, R., Freigang, K. D., Senges, J. C., Voss, F., Kraft, P., Kübler, W., & Schoels, W. (2000) · Basic Research in Cardiology · doi:10.1007/s003950070052 · Cited by 12
Linopirdine. A depolarization-activated releaser of transmitters for treatment of dementia.
Sw, T., & Zaczek, R. C. (1995) · PubMed · Cited by 12
Nassoiy, S. P., Babu, F. S., LaPorte, H. M., & Majetschak, M. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12845 · Cited by 12
Bock, C., Beirow, K., Surur, A. S., Schulig, L., Bodtke, A., Bednarski, P. J., & Link, A. (2018) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob02530d · Cited by 12
Aleo, M. D., Aubrecht, J., Bonin, P. D., Burt, D. A., Colangelo, J. L., Luo, L., Schomaker, S., Swiss, R. L., Kirby, S., Rigdon, G. C., et al. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.467 · Cited by 12
Sampath, D., Lam, P. M., Laoprasert, M., Diaz, M. J., Busquet, N., White, A. M., González, M. I., & Raol, Y. H. (2020) · Pediatric Research · doi:10.1038/s41390-019-0734-8 · Cited by 12
Pesti, J. A., Huhn, G. F., Yin, J., Xing, Y., Fortunak, J., & Earl, R. A. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo9804339 · Cited by 11
Porter, J. D., Vivas, O., Weaver, C. D., Alsafran, A., DiMilo, E., Arnold, L. A., Dickson, E. J., & Dockendorff, C. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126681 · Cited by 11
Tam, S. W., & Zaczek, R. C. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1857-0_7 · Cited by 11
Sander, S. E., Lambrecht, C., & Richter, A. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.017 · Cited by 10
Determination of linopirdine and its N-oxide metabolites in rat plasma by liquid chromatography
Rakestraw, D. C., Bilski, D. A., & Lam, G. N. (1994) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(94)e0040-8 · Cited by 9
Yang, S., Lu, D., & Ouyang, P. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.04.040 · Cited by 9
Kaplan, S., EHLKEN, B., & Hamann, X. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1499507 · Cited by 9
Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat
Gore, A., Neufeld-Cohen, A., Egoz, I., Baranes, S., Gez, R., Grauer, E., Chapman, S., & Lazar, S. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114963 · Cited by 9
Dörr, J., Wernecke, K., Wuerfel, J. T., Bellmann–Strobl, J., Siffrin, V., Sättler, M. B., Simons, M., Linsa, A., Tumani, H., & Paul, F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00842 · Cited by 8
Effect of salicylate on potassium currents in inner hair cells isolated from guinea-pig cochlea
Kimitsuki, T., Ohashi, M., 好啓, 梅., Yoshida, T., Komune, N., Noda, T., & Komune, S. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.050 · Cited by 7
Corici, C., Kohajda, Z., Kristóf, A., Horváth, A., Virág, L., Szél, T., Nagy, N., Szakonyi, Z., Fülöp, F., Muntean, D. M., et al. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0407 · Cited by 7
Zeng, H., Wang, J., Clouse, H., Lagrutta, A., & Sannajust, F. J. (2019) · JRSM Cardiovascular Disease · doi:10.1177/2048004019854919 · Cited by 7
Lee, J. H., Chae, M. R., Kang, S. J., Sung, H. H., Han, D. H., So, I., Park, J. K., & Lee, S. W. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02343-7 · Cited by 7
Diao, Y., Tian, Y., Han, S. K., Zhang, N., Li, J., & Yin, Y. (2017) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000175 · Cited by 6
Nissen, J. D., Thomsen, M. B., Bentzen, B. H., Diness, J. G., Diness, T. G., Jespersen, T., & Grunnet, M. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318238727a · Cited by 6
Mercado, F., Almanza, A., Rubio, N., & Soto, E. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.052 · Cited by 6
Recent Progress in the Discovery of Kv7 Modulators
Dorange, I. B., & Swahn, B. (2011) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-386009-5.00023-0 · Cited by 5
Migraine and epilepsy: Progress towards preemptive therapy
Haut, S. R., & Lipton, R. B. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.04.018 · Cited by 5
Diao, Y., Yan, W., Sun, W., Luo, Y., Li, J., & Yin, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27889 · Cited by 5
Evans, B., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., GOULD, N. P., Lundell, G. F., Homnick, C. F., Veber, D. F., et al. (1987) · ChemInform · doi:10.1002/chin.198750243 · Cited by 5
Development of an Electrophysiological Assay for Kv7 Modulators on IonWorks Barracuda
Wilenkin, B., Burris, K. D., Eastwood, B. J., Sher, E., Williams, A. C., & Priest, B. T. (2019) · Assay and Drug Development Technologies · doi:10.1089/adt.2019.942 · Cited by 3
Current and Emerging Solutions to Challenges in the Management of Alzheimer’s Disease
Atri, A., Goldfarb, D., Sheard, S., & Shaughnessy, L. W. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.ms18002ah3c · Cited by 3
A Complex Partnership: KCNQ1 and KCNE1
Seebohm, G. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.10.022 · Cited by 2
Pharmacologic Management Strategies in ALS #301
Scott, K., Shannon, R. P., Roche‐Green, A., Searcy, R. J., Woolyhand, G., Meeks, G., & Schuh, M. J. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2015.0362 · Cited by 2
Sudden cardiac death: improving our pathological diagnosis--are we there yet?
Morillo, C. A. (2014) · EP Europace · doi:10.1093/europace/eut433 · Cited by 1
Research works printed but not linked: 24
- Dorange, 2011, Annu. Rep. Med. Chem., 46, 53
- Brueggemann, 2012, Am. J. Physiol., 302, 120
- Jepps, 2009, Am. J. Physiol., 297, 107
- Herrmann, 1987, Postgrad. Med. J., 63, 87
- Barrese, 2010, Clin. Pharmacol., 2, 225
- H. Yu , Z.Lin , K.Xu , X.Huang , S.Long , M.Wu , O. B.McManus , J.Le Engers , M. E.Mattmann , D. W.Engers , U. M.Le , C. W.Lindsley , C. R.Hopkins and M.Li , Probe Reports from the NIH Molecular Libraries Program [Internet] , 2013
- Wickenden, 2000, Mol. Pharmacol., 58, 591, 10.1124/mol.58.3.591 · doi:10.1124/mol.58.3.591 · Paper page
- Zilliox, 2017, Continuum, 23, 512
- Atri, 2019, J. Clin. Psychiatry, 80, MS18002AH3C
- Repovic, 2019, Continuum, 25, 655
- Sheppard, 2014, Acta Otorhinolaryngol. Ital., 34, 79
- Shin, 2019, Hum. Mutat., 40, 335
- Su, 2012, Evid. Based Complement. Alternat. Med., 2012, 803082
- Xu, 2002, Am. J. Physiol., 283, 664
- Dalby-Brown, 2013, Eur. J. Pharmacol., 709, 52, 10.1016/j.ejphar.2013.03.039 · DOI
- D. E. Furst and T.Munster , in Nonsteroidal ant-inflammatory drugs, disease modifying antirheumatic drugs, nonopioid analgesics and drugs used in gout , ed. B. G. Katzung , McGraw-Hill Book Company , New York , 2001 , pp. 596–623
- Liu, 2014, Zhongguo Yaolixue Tongbao, 30, 574
- Ma, 2014, J. Chin. Pharm. Sci., 23, 153
- Kim, 2015, Nat. Commun., 6, 8116, 10.1038/ncomms9116 · DOI · Paper page
- Bett, 2006, J. Physiol., 576, 755, 10.1113/jphysiol.2006.116012 · DOI
- Zaczek, 1998, J. Pharmacol. Exp. Ther., 285, 724
- Yang, 2000, J. Pharmacol. Exp. Ther., 294, 955
- Zeng, 2019, JRSM Cardiovasc. Dis., 8, 2048004019854919
- Nattel, 1984, J. Pharmacol. Exp. Ther., 229, 283
Cited by
A small-molecule activation mechanism that directly opens the KCNQ2 channel
Zhang, S.-Y., Ma, D., Wang, K., Li, Y., Yang, Z., Li, X., Li, J., He, J., Mei, L., Ye, Y., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-023-01515-y · Cited by 32
“Efforts have been dedicated to identifying small molecules that enhance KCNQ2 currents, particularly at subthreshold voltages, in which increased KCNQ2 activity can effectively prevent abnormal or excessive neuronal firing 21,22 .”
Yan, Z., Zhong, L., Zhu, W., Chung, S. K., & Hou, P. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106765 · Cited by 33
Recent advances in the pharmacology of voltage-gated ion channels
Mateos, D. L., Harris, B. J., Hernández-González, A., Yarov-Yarovoy, V. M., & Wulff, H. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100090 · Cited by 31
Pinheiro, B. P., Müller, M. C., Bös, M., Guezguez, J., Burnet, M. W. M., Tornincasa, M., Rizzetto, R., Rolland, J., Liberati, C., Lohmer, S., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04915-5 · Cited by 21
Henton, A., Zhao, Y., & Tzounopoulos, T. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1070-22.2023 · Cited by 15
“KCNQ channels have been a successful target for drug development (Davoren et al., 2015; Manville and Abbott, 2018; Miceli et al., 2018; Seefeld et al., 2018; Ostacolo et al., 2020; Borgini et al., 2021).”
Background
Metadata
- Authors
- Borgini, M., Mondal, P., Liu, R., & Wipf, P.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Wipf, Peter
- Venue
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 12
- Issue
- 4
- Pages
- 483-537
- ISSN
- 2632-8682 (ISSN-L)
- PMC
- PMC8128042
- OpenAlex
- W3119057473
- Cited by
- 37
- References
- 386
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 10 · 2021: 1
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- RSC Medicinal Chemistry (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (W81XWH1810623)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Kv7 potassium channels, KCNQ channels, voltage-gated potassium channels, small molecule modulators, channel blockers, synthetic chemistry, medicinal chemistry, clinical properties
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.